Genetic epidemiology data have shown an association of certain combinations of inhibitory KIR and HLA‐C2 allotypes with adverse pregnancy outcomes, including RM [33], preeclampsia [34] and low birthweight [35]. This evidence concerns the gene KIR3DL1 and preeclampsia.